The Diagnostic Value of Cerebrospinal Fluid Neurogranin in Neurodegenerative Diseases
Author Information
Author(s): Krawczuk Daria, Mroczko Piotr, Winkel Izabela, Mroczko Barbara
Primary Institution: Medical University of Bialystok
Hypothesis
Cerebrospinal fluid neurogranin may serve as a biomarker for neurodegenerative diseases.
Conclusion
Cerebrospinal fluid neurogranin levels can help in the diagnosis and prognosis of neurodegenerative diseases like Alzheimer's, Parkinson's, and Creutzfeldt–Jacob's disease.
Supporting Evidence
- Cerebrospinal fluid neurogranin levels are correlated with cognitive decline in Alzheimer's disease.
- Neurogranin may help differentiate Alzheimer's disease from other types of dementia.
- High levels of cerebrospinal fluid neurogranin predict cognitive impairment in mild cognitive impairment patients.
Takeaway
Neurogranin is a protein in the brain that can help doctors figure out if someone has diseases like Alzheimer's or Parkinson's by looking at their spinal fluid.
Methodology
This review examines existing literature on cerebrospinal fluid neurogranin as a biomarker in neurodegenerative diseases.
Limitations
The review is based on existing studies, which may have varying methodologies and sample sizes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website